导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 22.97% | 195/1050 |
| 近一周 | -0.26% | 329/1104 |
| 近一月 | -4.29% | 696/1103 |
| 近一季 | -9.70% | 691/1092 |
| 近半年 | 18.93% | 174/1070 |
| 近一年 | 19.12% | 269/1018 |
| 近两年 | 84.55% | 280/926 |
| 近三年 | 53.71% | 248/834 |
| 成立以来 | 94.40% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.49% 684/1070 |
53.05% 215/1101 |
- - |
- - |
| 2025 | 26.43% 555/1065 |
5.43% 382/1014 |
1.78% 525/1038 |
27.50% 401/1050 |
-7.60% 822/1065 |
| 2024 | 1.36% 543/1011 |
-10.27% 777/960 |
-0.08% 312/983 |
13.95% 306/991 |
-0.80% 367/1011 |
| 2023 | -8.92% 296/952 |
-0.56% 651/880 |
0.87% 141/895 |
-7.59% 475/915 |
-1.74% 208/952 |
| 2022 | -24.07% 466/867 |
-19.98% 515/773 |
4.05% 580/806 |
-10.28% 258/845 |
1.64% 347/867 |
| 2021 | -4.75% 411/740 |
-5.15% 346/580 |
12.51% 295/659 |
-11.04% 534/704 |
0.33% 426/740 |
| 2020 | 59.61% 200/554 |
1.36% 126/419 |
25.74% 184/466 |
11.05% 227/517 |
12.78% 260/554 |
| 2019 | 58.26% 88/410 |
24.89% 713/1149 |
-1.00% 440/1231 |
11.99% 80/390 |
14.30% 65/410 |
| 2018 | -16.21% 35/349 |
- - |
- - |
- - |
-7.82% 142/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 景顺长城沪港深领先科技 VS. 东吴新产业精选股票A(580008) |